Genbioma Aplicaciones

Upcoming events Categories

About

Company description

Genbioma is a pioneering company in the nutraceutical industry, dedicated to revolutionizing the market with innovative microbiome-based ingredients aimed at metabolic syndrome management. Established in 2019 and headquartered in Spain, Genbioma has quickly positioned itself as a leader in the field, thanks to its cutting-edge research and development efforts.

Our flagship product, the postbiotic pA1c®HI, represents a significant breakthrough in the management of glucose levels for prediabetic and diabetic people. Extensive preclinical studies have been conducted to determine its mechanism of action through the modulation of the gut microbiota. Additionally, pA1c®HI has been clinically validated in an initial pilot trial, with several larger clinical trials currently underway. One of the key advantages of pA1c®HI is its stability and versatility. Unlike probiotic products, pA1c®HI does not require a cold chain for storage and transportation, making it highly convenient and cost-effective. This stability also allows it to be included in various food processing applications, even those involving heat, without losing its efficacy. The industrial-scale production of pA1c®HI is cost-effective, with a stability of three years under any thermal condition
Genbioma's value proposition is built on a scalable business model that ensures safety, effectiveness, and affordability. Our products comply with EFSA QPS and FDA GRAS standards, making them safe for consumption. At Genbioma, we are dedicated to improving health and wellness through scientifically validated products that offer real benefits to consumers. Our team of experts continues to push the boundaries of research and development, ensuring that we remain at the forefront of the nutraceutical industry.

Quick facts

Upcoming events